Skip to main content

Table 2 Correlation between MEG3 methylation probes and prognostic miRNAs

From: An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets

Methylation probe

Distance from MEG3 TSS

Correlation with 14q32 prognostic miRNAs

Number of miRNAs

Overlap with CTCF binding site

cg1656

1326

None

None

Near site (in promoter)

cg0928

775

0.466 (0.596 to 0.404)

7

In site (in promoter)

cg2583

156

0.459 (0.528 to 0.396)

3

Near site (in promoter)

cg05711

−218

−0.561

1

Near site (within gene body)

cg1537

−628

−0.443 (−0.408 to −0.631)

13

Near site (within gene body)

cg1510

−1264

0.546 (0.621 to 0.428)

2

Near site (within gene body)

cg0429

−1968

−0.283 (−0.554 to −0.552)

10

Not in site (within gene body)

  1. Locations of MEG3 promoter and gene body methylation probes with respect to MEG3 transcription start sites (TSSs), CTCF binding sites, and correlation with the 14q32 prognostic miRNAs associated with proliferation (p < 0.1)